Please login to the form below
golden triangle
This page shows the latest golden triangle news and features for those working in and with pharma, biotech and healthcare.
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for ... While the decision to locate the unit next to Illumina’s HQ isn’t unexpected,
Latest news
-
Servier begins construction of new R&D hub in Paris
in Boston’s Kendall Square, San Francisco and England’s ‘golden triangle’.
-
New biotech accelerator launched in Cambridge, UK
globally.”. Dr Jonathan Milner. “In this golden age of biology, Cambridge stands out as the world’s centre for healthcare innovation and translation,” says Dr Jonathan Milner, co-founder and deputy
-
AI specialist Exscientia buys Kinetic Discovery
There are close ties between the two companies, which both have their origins in the University of Dundee in Scotland but have relocated to the biotech ‘golden triangle’ in the southeast
-
MedCity sets up advanced therapy research network
Earlier this year, MedCity organised a showcase of cell and gene therapy expertise at eight National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs) in the ‘golden triangle’ extending between
-
London cancer hub launched by Cancer Research UK
The centre lies at the base of the UK’s often-cited Golden Triangle that extends out to Oxford and Cambridge, where a large proportion of the UK’s biotech research
More from news
Approximately 2 fully matching, plus 19 partially matching documents found.
Latest Intelligence
-
Unlocking the potential of science and technology in the UK
Some 17 of the 24 universities are based outside the ‘Golden Triangle’ of London, Oxford and Cambridge.
-
AstraZeneca: building a new ‘open innovation’ pharma company
Cambridge represents one corner of England’s larger ‘Golden Triangle’, which includes Oxford and London, and which is unquestionably Europe’s most important life sciences region.
-
Interview: AstraZeneca's Susan Galbraith
Soriot's ambitions for AZ include moving the company's research efforts in the UK to a hub in Cambridge - one tip of the so-called 'golden triangle' of research in
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Oxfordshire Bioscience Network Ltd
OBN is a not-for-profit business network providing comprehensive support for biotech, medtech and diagnostics member companies in the Golden Triangle biocluster and beyond, providing networking, partnering, group purchasing.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Account Director – UK Office
-
Excellent salary and benefits
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- AZ, Merck’s Lynparza scores market-expanding clinical success
- Moving annual total (MAT)
- GSK hires Merck KGaA exec to lead US pharma business
- Roche undercuts price of Bayer cancer drug after winning FDA approval
- Leaked no-deal Brexit document forecasts widespread shortages
- Novartis chooses internal replacement for US pharma president role
- Cello Health acquires US consultancy ISS
- Empowered patients: shaking the foundations of healthcare
- Roche’s Hemlibra scores broader NHS funding
- AZ’s Imfinzi combo bombs again in non-small cell lung cancer
- NICE’s fast-track catapults Skyrizi into market
- GSK files anaemia drug daprodustat in Japan, its first market
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
